This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Icon PLC (ICLR) Q1 Earnings Lag Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON
by Zacks Equity Research
Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON
4 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ERFSF vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ERFSF vs. ICLR: Which Stock Is the Better Value Option?
ERFSF vs. ICLR: Which Stock Is the Better Value Option?
by Zacks Equity Research
ERFSF vs. ICLR: Which Stock Is the Better Value Option?
Icon PLC (ICLR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.60% and 0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: ICON Public
by Zacks Equity Research
ICON Public Limited Company (ICLR) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?
by Zacks Equity Research
Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.
LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space
by Zacks Equity Research
The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resources.
Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 1.88% and 0.52%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICLR or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICLR vs. HQY: Which Stock Is the Better Value Option?
Icon PLC (ICLR) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 1.25% and 0.47%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN or ICLR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
Icon PLC (ICLR) Q3 Earnings Match Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and 0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher
by Zacks Equity Research
OncoCyte (OCX) was a big mover last session, as the company saw its shares rise more than 13% on the day.
Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.